Enzymotec Ltd. Granted U.S. Patent for INFAT to Promote Intestinal Development and Maturation

Enzymotec Ltd., ENZY, a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that INFAT®, the innovative ingredient that is marketed by Advanced Lipids, a joint venture of AAK and Enzymotec, has been granted a patent by the United States Patent and Trademark Office for uses related to intestinal development, maturation, adaptation and differentiation. Developed specifically for infant formula, INFAT® is a clinically-proven fat ingredient that closely resembles the composition, structure and nutritional value of natural fat in human breast milk that is necessary for proper infant health, development and comfort. "We are pleased to add another patent to our robust intellectual property portfolio. We remain focused on strengthening the unique benefits we provide to customers of INFAT® and proactively seek opportunities that will create additional value for our customers," commented Mr. Avner Avissara, CEO of Advanced Lipids and Enzymotec's VP of Sales for Infant Nutrition, Nutrition Division. "While this new patent pertains to INFAT®'s application for the promotion of intestinal development, maturation, adaptation and differentiation, it also complements another U.S. patent we have for INFAT®, which covers also the treatment of short bowel syndrome, inflammatory bowel diseases and necrotizing enterocolitis. We look forward to further developing the benefits of INFAT® and adding value to our customers." Previously published clinical data demonstrated that infants fed with formula containing INFAT® developed a similar variety of beneficial gut bacteria as breastfed babies. Beneficial gut bacteria promote good health and development and an ability to prevent infections. Additional clinical data also indicated that babies nourished with infant formula containing INFAT® cry less and for a shorter duration in comparison to babies fed with infant formula not containing INFAT®.